These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12404758)

  • 21. Sequence of changes in KK mouse nephropathy.
    Wehner H
    Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252
    [No Abstract]   [Full Text] [Related]  

  • 22. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
    Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
    Kumar GS; Shetty AK; Salimath PV
    J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glycosaminoglycans in diabetic nephropathy].
    Olszowska A
    Pol Merkur Lekarski; 2000 Dec; 9(54):873-5. PubMed ID: 11255659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report on an EFSD/Merck Travel Fellowship for Young Scientists. European Foundation for the Study of Diabetes. Glomerular enlargement in Type 1 and Type 2 diabetes.
    White K
    Diabetologia; 2000 Nov; 43(11):51-2. PubMed ID: 11126419
    [No Abstract]   [Full Text] [Related]  

  • 30. [Expression mechanisms and incident factors of diabetic nephropathy].
    Fujita T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():275-80. PubMed ID: 12430241
    [No Abstract]   [Full Text] [Related]  

  • 31. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase inhibition ameliorates experimental diabetic nephropathy.
    Huang L; Haylor JL; Hau Z; Jones RA; Vickers ME; Wagner B; Griffin M; Saint RE; Coutts IG; El Nahas AM; Johnson TS
    Kidney Int; 2009 Aug; 76(4):383-94. PubMed ID: 19553913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive insulin treatment reduces the accumulation of oxidation and glycation end-products in diabetic rat collagen.
    Traverso N; Odetti P; Pronzato MA; Marinari UM; Cottalasso D
    Aging (Milano); 1997 Dec; 9(6):432-3. PubMed ID: 9553625
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
    Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
    Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone expression is required for the development of diabetic glomerulosclerosis in mice.
    Liu ZH; Striker LJ; Phillips C; Chen NY; Chen WY; Kopchick JJ; Striker GE
    Kidney Int Suppl; 1995 Sep; 51():S37-8. PubMed ID: 7474687
    [No Abstract]   [Full Text] [Related]  

  • 38. Kidney disease in KK mice: structural, biochemical and functional relationships.
    Reddi AS; Wehner H; Khan MY; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():135-45. PubMed ID: 2854953
    [No Abstract]   [Full Text] [Related]  

  • 39. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of diabetic nephropathy.
    van Dijk C; Berl T
    Rev Endocr Metab Disord; 2004 Aug; 5(3):237-48. PubMed ID: 15211095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.